###begin article-title 0
Structural organization and interactions of transmembrane domains in tetraspanin proteins
###end article-title 0
###begin p 1
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
Proteins of the tetraspanin family contain four transmembrane domains (TM1-4) linked by two extracellular loops and a short intracellular loop, and have short intracellular N- and C-termini. While structure and function analysis of the larger extracellular loop has been performed, the organization and role of transmembrane domains have not been systematically assessed.
###end p 3
###begin title 4
Results
###end title 4
###begin p 5
###xml 97 104 97 104 <italic xmlns:xlink="http://www.w3.org/1999/xlink">abcdefg</italic>
###xml 97 104 97 104 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic>abcdefg</italic></bold>
###xml 105 106 105 106 <sub xmlns:xlink="http://www.w3.org/1999/xlink">n</sub>
###xml 125 127 125 127 <italic xmlns:xlink="http://www.w3.org/1999/xlink">a </italic>
###xml 125 127 125 127 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic>a </italic></bold>
###xml 193 195 193 195 <italic xmlns:xlink="http://www.w3.org/1999/xlink">d </italic>
###xml 193 195 193 195 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic>d </italic></bold>
###xml 260 262 260 262 <italic xmlns:xlink="http://www.w3.org/1999/xlink">a </italic>
###xml 260 262 260 262 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic>a </italic></bold>
###xml 330 332 330 332 <italic xmlns:xlink="http://www.w3.org/1999/xlink">d </italic>
###xml 330 332 330 332 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic>d </italic></bold>
###xml 400 402 400 402 <italic xmlns:xlink="http://www.w3.org/1999/xlink">a </italic>
###xml 400 402 400 402 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic>a </italic></bold>
###xml 503 505 503 505 <italic xmlns:xlink="http://www.w3.org/1999/xlink">d </italic>
###xml 503 505 503 505 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic>d </italic></bold>
###xml 1100 1102 1100 1102 <italic xmlns:xlink="http://www.w3.org/1999/xlink">g </italic>
###xml 1100 1102 1100 1102 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic>g </italic></bold>
###xml 1106 1107 1106 1107 <italic xmlns:xlink="http://www.w3.org/1999/xlink">c</italic>
###xml 1106 1107 1106 1107 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic>c</italic></bold>
###xml 1154 1155 1154 1155 <italic xmlns:xlink="http://www.w3.org/1999/xlink">d</italic>
###xml 1154 1155 1154 1155 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic>d</italic></bold>
###xml 1157 1159 1157 1159 <italic xmlns:xlink="http://www.w3.org/1999/xlink">g </italic>
###xml 1157 1159 1157 1159 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic>g </italic></bold>
###xml 1163 1164 1163 1164 <italic xmlns:xlink="http://www.w3.org/1999/xlink">a</italic>
###xml 1163 1164 1163 1164 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic>a</italic></bold>
###xml 1194 1196 1194 1196 <italic xmlns:xlink="http://www.w3.org/1999/xlink">a </italic>
###xml 1194 1196 1194 1196 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic>a </italic></bold>
###xml 1200 1202 1200 1202 <italic xmlns:xlink="http://www.w3.org/1999/xlink">d </italic>
###xml 1200 1202 1200 1202 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic>d </italic></bold>
###xml 1276 1281 1276 1281 <underline xmlns:xlink="http://www.w3.org/1999/xlink">intra</underline>
###xml 1337 1342 1337 1342 <underline xmlns:xlink="http://www.w3.org/1999/xlink">inter</underline>
###xml 9 14 <span type="species:ncbi:9606">human</span>
###xml 652 657 <span type="species:ncbi:9606">human</span>
Among 28 human tetraspanin proteins, the TM1-3 sequences display a distinct heptad repeat motif (abcdefg)n. In TM1, position a is occupied by structurally conserved bulky residues and position d contains highly conserved Asn and Gly residues. In TM2, position a is occupied by conserved small residues (Gly/Ala/Thr), and position d has a conserved Gly and two bulky aliphatic residues. In TM3, three a positions of the heptad repeat are filled by two leucines and a glutamate/glutamine residue, and two d positions are occupied by either Phe/Tyr or Val/Ile/Leu residues. No heptad motif is apparent in TM4 sequences. Mutations of conserved glycines in human CD9 (Gly25 and Gly32 in TM1; Gly67 and Gly74 in TM2) caused aggregation of mutant proteins inside the cell. Modeling of the TM1-TM2 interface in CD9, using a novel algorithm, predicts tight packing of conserved bulky residues against conserved Gly residues along the two helices. The homodimeric interface of CD9 was mapped, by disulfide cross-linking of single-cysteine mutants, to the vicinity of residues Leu14 and Phe17 in TM1 (positions g and c) and Gly77, Gly80 and Ala81 in TM2 (positions d, g and a, respectively). Mutations of a and d residues in both TM1 and TM2 (Gly25, Gly32, Gly67 and Gly74), involved in intramolecular TM1-TM2 interaction, also strongly diminished intermolecular interaction, as assessed by cross-linking of Cys80.
###end p 5
###begin title 6
Conclusion
###end title 6
###begin p 7
Our results suggest that tetraspanin intra- and intermolecular interactions are mediated by conserved residues in adjacent, but distinct regions of TM1 and TM2. A key structural element that defines TM1-TM2 interaction in tetraspanins is the specific packing of bulky residues against small residues.
###end p 7
###begin title 8
Background
###end title 8
###begin p 9
###xml 326 327 326 327 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 328 329 328 329 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 399 423 399 423 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drosophila melanogaster </italic>
###xml 433 455 433 455 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Caenorhabditis elegans</italic>
###xml 593 594 593 594 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 595 596 595 596 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 785 786 785 786 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 787 788 787 788 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 797 798 797 798 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 799 800 799 800 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 810 812 810 812 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 399 422 <span type="species:ncbi:7227">Drosophila melanogaster</span>
###xml 433 455 <span type="species:ncbi:6239">Caenorhabditis elegans</span>
###xml 743 748 <span type="species:ncbi:10090">mouse</span>
Tetraspanins constitute a large family of integral membrane proteins, characteristically containing 4, 6 or 8 conserved cysteine residues in the large extracellular loop (including the CCG and PxxCC motifs), which form disulfide bonds, and several conserved polar residues in the intracellular loop and transmembrane regions [1,2]. There are 32 putative tetraspanin family members in mammals, 37 in Drosophila melanogaster and 20 in Caenorhabditis elegans. Tetraspanins play diverse roles in cell adhesion, migration and fusion processes, cellular activation and signaling (reviewed in refs. [2-4]). Mammalian tetraspanins such as CD9, CD63, CD81, CD82, CD151, rds/peripherin, and uroplakins Ia and Ib have been most extensively studied, with mouse knock-out models available for CD9 [5-7], CD81 [8,9], CD151 [10] and a few others. However, the majority of tetraspanins are characterized very little, if at all, at genetic, biochemical or structural levels.
###end p 9
###begin p 10
###xml 312 314 312 314 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 418 420 418 420 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 503 505 499 501 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 644 646 640 642 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
The large extracellular loop (LEL) of tetraspanins has received most attention, since it contains functionally important sites. Sequence QRD (194-196) in CD151 is important for association with integrins, which has functional consequences for integrin-dependent cell spreading and multicellular cable formation [11]. A site in the LEL of CD9, SFQ (residues 173-175), is essential for CD9 function in sperm-egg fusion [12]. The crystal structure of tetraspanin CD81 LEL revealed five alpha-helixes, A-E [13]. Helices A, B and E form a relatively conserved region in tetraspanins, whereas the region between helices B and E is the most variable [14]. Interestingly, the variable region contains most of the functionally important sites involved in tetraspanin protein-protein interactions.
###end p 10
###begin p 11
###xml 278 279 278 279 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 280 281 280 281 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 282 284 282 284 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 567 569 567 569 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 640 642 640 642 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 643 645 643 645 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 784 786 784 786 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 787 789 787 789 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
A remarkable biochemical property of tetraspanin molecules is their ability to associate with a large number of other transmembrane proteins, including integrins, membrane-associated growth factors and receptors, MHC class II molecules, Ig superfamily proteins, and each other [2,3,15]. Several of these lateral associations of tetraspanins are detected in "mild" detergents (Brij series, CHAPS), but are disrupted by "strong" detergents such as Triton X-100 or SDS. Multiprotein complexes of tetraspanins and associated molecules, also called the "tetraspanin web" [16], may represent a distinct tetraspanin-enriched membrane microdomain [17,18]. The formation of this microdomain is influenced by palmitoylation of several conserved juxtamembrane cysteine residues in tetraspanins [19-21].
###end p 11
###begin p 12
###xml 129 136 129 136 <italic xmlns:xlink="http://www.w3.org/1999/xlink">et al. </italic>
###xml 137 138 137 138 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 520 522 520 522 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
The transmembrane domains, encompassing nearly half of a tetraspanin protein, are the most conserved part of the molecule (Stipp et al. [1] and this study). However, very little functional information is available on these domains. The differential detergent sensitivity of tetraspanin-tetraspanin associations suggests that hydrophobic interactions between TM helices may play a role. Indeed, when the large extracellular loop (LEL) of CD151 is deleted, the molecule is still able to associate with other tetraspanins [22]. Thus, TM domains are strong candidates for mediating tetraspanin-tetraspanin interactions.
###end p 12
###begin p 13
###xml 257 259 257 259 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 267 275 267 275 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo </italic>
###xml 721 723 721 723 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
The importance of TM domain interactions in intramolecular organization was demonstrated in a study showing that CD82 fragment TM2-4, lacking TM1, was retained in the endoplasmic reticulum, but was transported to the cell surface upon co-expression of TM1 [23]. This in vivo reconstitution experiment demonstrated a strong interaction between TM1 and the rest of the molecule. Expression of a truncated CD9 molecule (TM3-LEL-TM4) results in intracellular accumulation of the protein and significant misfolding of the LEL, as judged by inappropriate disulfide formation and diminished antibody reactivity (our unpublished data). Similarly, a CD9 epitope in the LEL is lost in molecules lacking either TM2+TM3 or just TM4 [24]. Thus, TM domain interactions and packing are crucial for proper folding, stability and transport of tetraspanin molecules.
###end p 13
###begin p 14
###xml 175 177 175 177 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
In a previous study, we showed that covalent cross-linking of membrane-proximal cysteine residues can be used as a tool for detection of tetraspanin-tetraspanin associations [25]. Inhibition of cysteine palmitoylation by 2-bromopalmitate (2-BP) made cysteines available for cross-linking and enabled demonstration of specific tetraspanin homodimerization and low levels of heterodimerization. We concluded that tetraspanin homodimers, formed in the Golgi, may be a fundamental structural unit within tetraspanin microdomains.
###end p 14
###begin p 15
###xml 60 65 <span type="species:ncbi:9606">human</span>
###xml 430 435 <span type="species:ncbi:9606">human</span>
In this study, we carried out detailed sequence analysis of human tetraspanin TM domains. We show that a heptad repeat containing conserved glycine, asparagine and large hydrophobic residues occurs in TM1 and TM2 domains, and predict tight intramolecular association of these two domains by packing of the large residues against the small residues. Moreover, by using cysteine cross-linking we map a dimerization interface in the human CD9 protein, and show that conserved heptad motif glycine residues are also important for intermolecular CD9 associations.
###end p 15
###begin title 16
Results
###end title 16
###begin title 17
Sequence analysis of tetraspanin transmembrane domains: presence of the heptad repeat motif
###end title 17
###begin p 18
###xml 371 373 371 373 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 456 458 456 458 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 459 461 459 461 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 582 584 582 584 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 585 587 585 587 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B28">28</xref>
###xml 31 36 <span type="species:ncbi:9606">human</span>
We focused our attention on 28 human tetraspanins identified from the SWISS-PROT and GenBank databases. All tetraspanins have in common four hydrophobic stretches (TM domains) of 20-25 residues, and contain highly conserved residues in the second extracellular loop, in particular the Cys-Cys-Gly (CCG) motif. Detailed analysis of the large extracellular loop sequences [14], and dendrograms based on full-length alignment can be found in earlier studies [26,27]. The length of each transmembrane domain was established based on previous sequence analysis of tetraspanin sequences [27,28], and on annotations to the database entries. Manual adjustments based on sequence homology and hydrophobicity profiles were done to fully delineate the TM domains. The resulting lengths of TM domains were: TM1 - 23 residues; TM2 - 21 residues; TM3 - 25 residues; TM4 - 25 residues. Two more residues could be added onto the N-terminal part of TM2; however, relatively small sequence conservation of these residues among tetraspanins and occurrence of polar/charged side chains in some tetraspanins precluded us from doing so for the global alignment.
###end p 18
###begin p 19
###xml 8 9 8 9 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 14 15 14 15 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2</xref>
###xml 541 542 541 542 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 76 81 <span type="species:ncbi:9606">human</span>
###xml 766 771 <span type="species:ncbi:9606">human</span>
Figures 1 and 2 show a multiple sequence alignment of four TM domains of 28 human tetraspanins. For each position within the domains, consensus residues were determined and classified (with individual color code) in 4 categories: 1) large hydrophobic residues (including Val, Met, Leu, Ile, Phe, Tyr, Trp), 2) small residues (Gly, Ala, Ser and Thr), 3) Cys, and 4) Asn. When more than two types of residues occupied a given position in a TM, a dual-color pattern that reflected the prevalence of the particular residue type was used (Figure 1). Cysteine residues were shown separately due to their importance as palmitoylation target sites. The highly conserved asparagine residue in TM1 was considered separately. No proline residues are found in TM domains 1-3 of human tetraspanins.
###end p 19
###begin p 20
###xml 97 104 97 104 <italic xmlns:xlink="http://www.w3.org/1999/xlink">abcdefg</italic>
###xml 97 104 97 104 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic>abcdefg</italic></bold>
###xml 105 106 105 106 <sub xmlns:xlink="http://www.w3.org/1999/xlink">n</sub>
###xml 132 133 132 133 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 135 136 135 136 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2</xref>
###xml 247 249 247 249 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B29">29</xref>
###xml 250 252 250 252 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B31">31</xref>
###xml 311 313 311 313 <italic xmlns:xlink="http://www.w3.org/1999/xlink">a </italic>
###xml 311 313 311 313 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic>a </italic></bold>
###xml 317 319 317 319 <italic xmlns:xlink="http://www.w3.org/1999/xlink">d </italic>
###xml 317 319 317 319 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic>d </italic></bold>
###xml 468 470 468 470 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B32">32</xref>
###xml 559 561 559 561 <italic xmlns:xlink="http://www.w3.org/1999/xlink">a </italic>
###xml 559 561 559 561 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic>a </italic></bold>
###xml 565 567 565 567 <italic xmlns:xlink="http://www.w3.org/1999/xlink">d </italic>
###xml 565 567 565 567 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic>d </italic></bold>
###xml 643 645 643 645 <italic xmlns:xlink="http://www.w3.org/1999/xlink">a </italic>
###xml 643 645 643 645 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic>a </italic></bold>
###xml 711 713 711 713 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B33">33</xref>
###xml 516 521 <span type="species:ncbi:4932">yeast</span>
An inspection of the multiple sequence alignment reveals a repeating heptad amino acid pattern, (abcdefg)n, in TM1, 2 and 3 (Figure 1, 2). Heptad repeats promote helical coiled coil interactions in multiple soluble and membrane-spanning proteins [29-31]. In the heptad repeat, hydrophobic residues in positions a and d are of special importance, as they directly mediate interhelical contacts by creating a tight knobs-into-holes packing in the coiled coil structure [32]. For instance, in the leucine zipper of the yeast transcription factor GCN4, positions a and d contain Val and Leu residues, respectively, with an Asn residue in a single a position forming a hydrogen bond across the GCN4 dimer interface [33].
###end p 20
###begin p 21
###xml 121 123 121 123 <italic xmlns:xlink="http://www.w3.org/1999/xlink">d </italic>
###xml 121 123 121 123 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic>d </italic></bold>
###xml 190 192 190 192 <italic xmlns:xlink="http://www.w3.org/1999/xlink">a </italic>
###xml 190 192 190 192 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic>a </italic></bold>
###xml 210 211 210 211 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 295 297 295 297 <italic xmlns:xlink="http://www.w3.org/1999/xlink">a </italic>
###xml 295 297 295 297 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic>a </italic></bold>
###xml 346 348 346 348 <italic xmlns:xlink="http://www.w3.org/1999/xlink">d </italic>
###xml 346 348 346 348 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic>d </italic></bold>
###xml 414 417 414 417 <sup xmlns:xlink="http://www.w3.org/1999/xlink">rd </sup>
###xml 417 419 417 419 <italic xmlns:xlink="http://www.w3.org/1999/xlink">g </italic>
###xml 417 419 417 419 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic>g </italic></bold>
###xml 567 569 567 569 <italic xmlns:xlink="http://www.w3.org/1999/xlink">a </italic>
###xml 567 569 567 569 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic>a </italic></bold>
###xml 587 588 587 588 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2</xref>
###xml 595 597 595 597 <italic xmlns:xlink="http://www.w3.org/1999/xlink">d </italic>
###xml 595 597 595 597 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic>d </italic></bold>
###xml 859 860 859 860 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3</xref>
In TM1 of tetraspanins, highly conserved Asn, Gly and Gly residues (numbers 18, 25 and 32 in the CD9 sequence) appear at d positions of the heptad repeats, and residues 14, 21 and 28 are at a positions (Figure 1). In TM2, residues 67, 74 and 81 (consensus Gly, Gly and Ala, respectively) occupy a positions, whereas residues 63, 70 and 77 are at d positions. Another highly conserved glycine, Gly80, occupies the 3rd g position in TM2. In TM3, the conserved pattern consists of two leucine residues (Leu89 and Leu96) and a glutamate/glutamine residue (Glu/Gln103) in a positions (Figure 2). Two d positions are also conserved - Phe/Tyr92 and Ile/Val/Leu99. TM4 lacks a conserved heptad pattern and has only a single conserved position, Glu/Gln209 (with four exceptions). These features of TM1-4 of tetraspanins are displayed on helical wheel diagrams (Figure 3).
###end p 21
###begin title 22
Analysis of TM1 sequences
###end title 22
###begin p 23
###xml 54 56 54 56 <italic xmlns:xlink="http://www.w3.org/1999/xlink">d </italic>
###xml 54 56 54 56 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic>d </italic></bold>
###xml 348 349 348 349 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4</xref>
###xml 361 362 361 362 <italic xmlns:xlink="http://www.w3.org/1999/xlink">a</italic>
###xml 361 362 361 362 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic>a</italic></bold>
###xml 364 366 364 366 <italic xmlns:xlink="http://www.w3.org/1999/xlink">d </italic>
###xml 364 366 364 366 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic>d </italic></bold>
###xml 370 372 370 372 <italic xmlns:xlink="http://www.w3.org/1999/xlink">g </italic>
###xml 370 372 370 372 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic>g </italic></bold>
###xml 515 517 515 517 <italic xmlns:xlink="http://www.w3.org/1999/xlink">b </italic>
###xml 515 517 515 517 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic>b </italic></bold>
###xml 536 538 536 538 <italic xmlns:xlink="http://www.w3.org/1999/xlink">c </italic>
###xml 536 538 536 538 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic>c </italic></bold>
###xml 557 559 557 559 <italic xmlns:xlink="http://www.w3.org/1999/xlink">e </italic>
###xml 557 559 557 559 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic>e </italic></bold>
###xml 581 583 581 583 <italic xmlns:xlink="http://www.w3.org/1999/xlink">f </italic>
###xml 581 583 581 583 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic>f </italic></bold>
###xml 670 672 670 672 <italic xmlns:xlink="http://www.w3.org/1999/xlink">a </italic>
###xml 670 672 670 672 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic>a </italic></bold>
###xml 676 677 676 677 <italic xmlns:xlink="http://www.w3.org/1999/xlink">d</italic>
###xml 676 677 676 677 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic>d</italic></bold>
The conserved Asn-Gly-Gly motif, occupying designated d positions of the heptad repeat, is the most prominent structural feature of TM1. We also compared sequences of CD9 orthologs from 10 different organisms (the most available for any tetraspanin) to gain further insight into conservation and variability of the TM1 sequence. As shown in Figure 4, positions a, d and g in TM1 are among the most conserved (0, 1 and 1 substitution, respectively), while interspecies variability tends to occur in other positions: b (5 substitutions), c (4 substitutions), e (4 substitutions) and f (4 substitutions). Thus, the positions typically involved in coiled coil interactions (a and d) are the most conserved.
###end p 23
###begin p 24
###xml 105 106 105 106 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3</xref>
###xml 187 189 187 189 <italic xmlns:xlink="http://www.w3.org/1999/xlink">a </italic>
###xml 187 189 187 189 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic>a </italic></bold>
###xml 266 268 266 268 <italic xmlns:xlink="http://www.w3.org/1999/xlink">g </italic>
###xml 266 268 266 268 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic>g </italic></bold>
###xml 427 429 427 429 <italic xmlns:xlink="http://www.w3.org/1999/xlink">d </italic>
###xml 427 429 427 429 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic>d </italic></bold>
###xml 449 450 449 450 <italic xmlns:xlink="http://www.w3.org/1999/xlink">b</italic>
###xml 449 450 449 450 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic>b</italic></bold>
###xml 452 453 452 453 <italic xmlns:xlink="http://www.w3.org/1999/xlink">c</italic>
###xml 452 453 452 453 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic>c</italic></bold>
###xml 455 457 455 457 <italic xmlns:xlink="http://www.w3.org/1999/xlink">e </italic>
###xml 455 457 455 457 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic>e </italic></bold>
###xml 461 463 461 463 <italic xmlns:xlink="http://www.w3.org/1999/xlink">f </italic>
###xml 461 463 461 463 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic>f </italic></bold>
When residues of TM1 are plotted as a helical wheel, additional structural features are revealed (Figure 3). There are highly conserved aliphatic and aromatic residues in the first three a positions of the heptad motif (Phe15, Trp22 and Leu29 in CD9), as well as in g positions (Leu14, Phe21, Val28 in CD9). The "ridges" formed by these bulky residues are flanking the "groove"-forming Gly residues of the Asn-Gly-Gly position d motif. In contrast, b, c, e and f positions show an overall higher variability among tetraspanins, as also seen in the comparison of CD9 orthologs described above.
###end p 24
###begin title 25
Analysis of TM2 sequences
###end title 25
###begin p 26
###xml 132 133 132 133 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 339 341 339 341 <italic xmlns:xlink="http://www.w3.org/1999/xlink">a </italic>
###xml 339 341 339 341 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic>a </italic></bold>
###xml 379 380 379 380 <italic xmlns:xlink="http://www.w3.org/1999/xlink">d</italic>
###xml 379 380 379 380 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic>d</italic></bold>
###xml 547 549 547 549 <italic xmlns:xlink="http://www.w3.org/1999/xlink">g </italic>
###xml 547 549 547 549 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic>g </italic></bold>
###xml 557 558 557 558 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3</xref>
###xml 599 601 599 601 <italic xmlns:xlink="http://www.w3.org/1999/xlink">a </italic>
###xml 599 601 599 601 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic>a </italic></bold>
###xml 605 607 605 607 <italic xmlns:xlink="http://www.w3.org/1999/xlink">d </italic>
###xml 605 607 605 607 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic>d </italic></bold>
###xml 701 703 701 703 <italic xmlns:xlink="http://www.w3.org/1999/xlink">b </italic>
###xml 701 703 701 703 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic>b </italic></bold>
###xml 708 710 708 710 <italic xmlns:xlink="http://www.w3.org/1999/xlink">c </italic>
###xml 708 710 708 710 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic>c </italic></bold>
###xml 715 717 715 717 <italic xmlns:xlink="http://www.w3.org/1999/xlink">e </italic>
###xml 715 717 715 717 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic>e </italic></bold>
###xml 722 724 722 724 <italic xmlns:xlink="http://www.w3.org/1999/xlink">f </italic>
###xml 722 724 722 724 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic>f </italic></bold>
###xml 729 731 729 731 <italic xmlns:xlink="http://www.w3.org/1999/xlink">g </italic>
###xml 729 731 729 731 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic>g </italic></bold>
###xml 743 744 743 744 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4</xref>
###xml 758 760 758 760 <italic xmlns:xlink="http://www.w3.org/1999/xlink">f </italic>
###xml 758 760 758 760 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic>f </italic></bold>
###xml 864 865 864 865 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 867 868 867 868 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3</xref>
A landmark feature of TM2 in tetraspanins is the presence of highly conserved glycine residues (Gly67, 74, 77 and 80 in CD9, Figure 1). Other substitutions at these positions are almost exclusively small residues, such as Ala or Ser. In addition, Ala, Ser or Thr occupy position 81. This residue, together with Gly67 and Gly74, forms face a of the helix. Residue Gly77 (position d) is preceded by conserved, chiefly large hydrophobic residues on the same helical face (Leu63 and Met70 in CD9). Extremely conserved Gly80 falls into heptad position g (Figure 3). Among CD9 orthologs, heptad positions a and d are absolutely conserved, whereas other positions have the following number of substitutions: b - 3; c - 2; e - 1; f - 3; g - 1 (Figure 4). Two of the f position residues in TM2 (65 and 79) also show higher variability among different tetraspanins (Figures 1, 3). Cysteine residues are frequently found near the cytoplasmic end of TM2 helix at positions 78 and 79; these cysteines are likely to be palmitoylated.
###end p 26
###begin title 27
Analysis of TM3 and TM4 sequences
###end title 27
###begin p 28
###xml 79 81 79 81 <italic xmlns:xlink="http://www.w3.org/1999/xlink">a </italic>
###xml 79 81 79 81 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic>a </italic></bold>
###xml 214 216 214 216 <italic xmlns:xlink="http://www.w3.org/1999/xlink">d </italic>
###xml 214 216 214 216 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic>d </italic></bold>
###xml 327 328 324 325 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2</xref>
###xml 330 331 327 328 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3</xref>
###xml 371 373 368 370 <italic xmlns:xlink="http://www.w3.org/1999/xlink">e </italic>
###xml 371 373 368 370 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic>e </italic></bold>
###xml 428 430 425 427 <italic xmlns:xlink="http://www.w3.org/1999/xlink">a </italic>
###xml 428 430 425 427 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic>a </italic></bold>
###xml 460 461 457 458 <italic xmlns:xlink="http://www.w3.org/1999/xlink">b</italic>
###xml 460 461 457 458 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic>b</italic></bold>
###xml 463 465 460 462 <italic xmlns:xlink="http://www.w3.org/1999/xlink">c </italic>
###xml 463 465 460 462 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic>c </italic></bold>
###xml 469 471 466 468 <italic xmlns:xlink="http://www.w3.org/1999/xlink">f </italic>
###xml 469 471 466 468 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic>f </italic></bold>
###xml 494 496 491 493 <italic xmlns:xlink="http://www.w3.org/1999/xlink">d </italic>
###xml 494 496 491 493 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic>d </italic></bold>
###xml 500 502 497 499 <italic xmlns:xlink="http://www.w3.org/1999/xlink">e </italic>
###xml 500 502 497 499 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic>e </italic></bold>
###xml 519 521 516 518 <italic xmlns:xlink="http://www.w3.org/1999/xlink">g </italic>
###xml 519 521 516 518 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic>g </italic></bold>
###xml 564 566 561 563 <italic xmlns:xlink="http://www.w3.org/1999/xlink">a </italic>
###xml 564 566 561 563 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic>a </italic></bold>
###xml 570 572 567 569 <italic xmlns:xlink="http://www.w3.org/1999/xlink">d </italic>
###xml 570 572 567 569 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic>d </italic></bold>
###xml 670 671 667 668 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3</xref>
###xml 804 805 801 802 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2</xref>
The TM3 domain provides another example of the heptad repeat pattern. Position a is occupied by two highly conserved leucine and a glutamate/glutamine residue (Leu89, Leu96 and Glu/Gln103 in CD9). Furthermore, two d positions are conserved - Phe/Tyr92 (aromatic residue) and Ile/Val99 (beta-branched aliphatic residue; Figures 2, 3). In addition, residue 100 in position e is generally Phe or Leu. Among CD9 orthologs, position a has 1 substitution, positions b, c and f each have 6, positions d and e each have 2, and g has 4. Thus, as for TM1 and TM2, positions a and d are among the most conserved, but overall TM3 has more variable positions than TM1 or TM2 (Figure 3). Less than half of TM3 sequences contain cysteine residues, and those tend to occur at the internal positions of the helix (Figure 2).
###end p 28
###begin p 29
###xml 104 105 104 105 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2</xref>
###xml 107 108 107 108 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3</xref>
TM4 shows less conservation among various tetraspanin family members than the other TM domains (Figures 2, 3). The only highly conserved feature is the glutamate/glutamine residue in position 209. In addition, one or two cysteine residues can be found at the C-terminal end of TM4 in some tetraspanins (e.g. CD9, CD81, CD151), and many sequences contain additional polar residues (Arg, Lys, His, Asn, Gln). No conserved heptad motif was identified in TM4, as also confirmed by analysis of substitutions in CD9 orthologs (data not shown).
###end p 29
###begin title 30
Mutational analysis of conserved glycine residues in TM1 and TM2
###end title 30
###begin p 31
###xml 558 559 558 559 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5</xref>
###xml 746 747 746 747 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5</xref>
###xml 850 851 850 851 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5</xref>
###xml 395 400 <span type="species:ncbi:9606">human</span>
###xml 1206 1211 <span type="species:ncbi:9606">human</span>
The conserved nature of the Asn and Gly residues in TM1 and TM2 prompted an analysis of their functional role. To this end, we have probed whether mutations of these residues destabilize the protein molecule. We expressed a construct of the first and second TMs of CD9, connected by the small extracellular loop, and tagged with a C-terminal green fluorescent protein (TM(1+2)-GFP molecule). In human rhabdomyosarcoma RD cells, the wild-type fusion protein localized mostly in a reticular, intracellular pattern, without forming any large aggregates (Figure 5, panel A). Remarkably, when double mutants Gly25Leu + Gly32Leu and Gly67Leu + Gly74Leu were expressed, the protein formed distinct large aggregates in a high proportion of cells (Figure 5, panels C and E). In contrast, double mutant Gly77Leu + Gly80Leu did not form such aggregates (Figure 5, panel G). Results with respective single mutants were similar to that with double mutants, with the aggregation being somewhat more pronounced for Leu substitutions of Gly67 and Gly74 compared to Gly25 and Gly32 mutations. No aggregation was observed for Asn18Ser and Asn18Tyr mutants (data not shown). Also, nearly identical results were obtained with human HT1080 cells (data not shown).
###end p 31
###begin p 32
###xml 677 679 677 679 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B34">34</xref>
###xml 698 699 698 699 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5</xref>
###xml 818 819 818 819 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5</xref>
###xml 878 879 878 879 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5</xref>
We interpret these results as an indication that aggregating mutants are destabilized or misfolded while non-aggregating mutants retain the wild-type conformation. Intriguingly, mutations to the conserved GG7 motifs caused protein aggregation while the mutation of other glycines had no detectable effect. These results also suggest that wild-type GFP, which has weak tendency to self-associate, could enhance non-specific interactions of destabilized mutant TM(1+2) CD9 moieties, leading to their aggregation. Consistent with this hypothesis, the aggregation of Gly25Leu + Gly32Leu and Gly67Leu + Gly74Leu double mutants was suppressed when monomeric GFP molecule, Leu221Lys [34] was used (Figure 5, panels D and F). The use of monomeric GFP did not affect intercellular localization of wild-type CD9 TM(1+2) (Figure 5, panel B), or a Gly77Leu + Gly80Leu double mutant (Figure 5, panel H).
###end p 32
###begin p 33
###xml 295 296 295 296 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3</xref>
In summary, Leu substitutions of Gly residues that are part of the Asn-Gly-Gly (NGG7) motif in TM1, or Gly-Gly-Ala (GGA7) motif in TM2, resulted in destabilization and aggregation of GFP-fused TM(1+2) proteins, whereas substitutions of Gly77 or Gly80, which are not part of these motifs (Figure 3), failed to show such aggregation.
###end p 33
###begin title 34
Prediction and modelling of interaction between TM1 and TM2
###end title 34
###begin p 35
###xml 72 74 72 74 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B35">35</xref>
###xml 239 241 239 241 <italic xmlns:xlink="http://www.w3.org/1999/xlink">a </italic>
###xml 239 241 239 241 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic>a </italic></bold>
###xml 245 247 245 247 <italic xmlns:xlink="http://www.w3.org/1999/xlink">d </italic>
###xml 245 247 245 247 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic>d </italic></bold>
###xml 278 279 278 279 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3</xref>
###xml 542 550 542 550 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Methods </italic>
###xml 780 781 780 781 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5</xref>
Consecutive helices in polytopic membrane proteins frequently interact [35]. Sequence analysis of TM1 and TM2 helices of tetraspanins reveals a remarkable complementarity in the distribution of large and small residues at heptad positions a and d along the helical axis (Figure 3), suggesting that these residues may interact. To further elucidate the potential for TM1-TM2 interaction, the putative interface was modeled using a novel algorithm that considers mutational data during each step of a Monte Carlo simulated annealing cycle (see Methods for details). Specifically, Gly25Leu, Gly32Leu, Gly67Leu and Gly74Leu were scored as disruptive mutations, while Asn18Ser, Gly77Leu and Gly80Leu were scored as silent mutations, based on their effects on protein stability (Figure 5 and data not shown).
###end p 35
###begin p 36
###xml 186 188 180 182 <italic xmlns:xlink="http://www.w3.org/1999/xlink">a </italic>
###xml 186 188 180 182 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic>a </italic></bold>
###xml 192 194 186 188 <italic xmlns:xlink="http://www.w3.org/1999/xlink">d </italic>
###xml 192 194 186 188 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic>d </italic></bold>
###xml 301 302 295 296 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6</xref>
###xml 485 491 479 481 <sub xmlns:xlink="http://www.w3.org/1999/xlink">&#945; </sub>
###xml 528 534 518 520 <sub xmlns:xlink="http://www.w3.org/1999/xlink">&#945; </sub>
###xml 641 642 627 628 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6</xref>
###xml 672 677 658 659 <sub xmlns:xlink="http://www.w3.org/1999/xlink">&#945;</sub>
###xml 679 685 661 663 <sub xmlns:xlink="http://www.w3.org/1999/xlink">&#945; </sub>
The resulting model predicts left-handed crossing of TM1 and TM2 helices at an angle of +28degrees. The key element of the structure is the apposition of bulky and small heptad position a and d residues, as follows: Gly32-Leu63; Gly67-Leu29; Gly25-Met70; Gly74-Trp22; Asn18-Gly77; Ala81-Phe15 (Figure 6). Our model predicts that each of these residue pairs are in van der Waals contact. Additionally, two potential H-bonds are predicted in this model, indicating close packing: Gly67 Calpha to Gly25 carbonyl oxygen, and Trp22 Calpha to Met70 carbonyl oxygen. The packing is tighter in the ectodomain-proximal portion of the helices (Figure 6, panel B), as determined by Calpha-Calpha distances between interacting residue pairs.
###end p 36
###begin p 37
###xml 164 165 164 165 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 372 373 372 373 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 522 527 522 524 <sub xmlns:xlink="http://www.w3.org/1999/xlink">&#946; </sub>
###xml 781 785 772 773 <sub xmlns:xlink="http://www.w3.org/1999/xlink">&#946;</sub>
###xml 937 942 925 927 <sub xmlns:xlink="http://www.w3.org/1999/xlink">&#946; </sub>
The key elements of the model are corroborated by the presence of apparently complementary substitutions in TM1 and TM2 sequences of different tetraspanins (Figure 1, boxed residues). For example, Gly74 is predicted to interact with Trp22. In 8 of the 10 tetraspanins that contain a substitution for Gly74, a compensatory substitution occurs at the Trp22 position (Figure 1). Thus, a larger non-glycine side chain at position 74 may necessitate a less bulky non-Trp side chain in position 22. Likewise, the presence of a Cbeta at position 25, typically occupied by glycine, necessitates a non-beta-branched amino acid at position 70, which is occupied by a beta-branched residue in nearly half of all cases. Indeed, we find that in each of 5 cases in which position 25 contains a Cbeta, a leucine residue occurs in position 70. This analysis is consistent with our molecular model that suggests Leu70 will pack most favorably against a Cbeta at position 25 than a beta-branched residue or a methionine.
###end p 37
###begin title 38
Role of TM1 and TM2 heptad motif residues in CD9 dimerization
###end title 38
###begin p 39
###xml 172 174 172 174 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
###xml 458 466 458 466 <italic xmlns:xlink="http://www.w3.org/1999/xlink">In situ </italic>
###xml 520 522 520 522 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 584 592 584 592 <italic xmlns:xlink="http://www.w3.org/1999/xlink">In situ </italic>
###xml 1244 1246 1244 1246 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
To probe CD9 dimerization, we used a cysteine-mediated cross-linking approach. We established previously a simple and efficient method for cysteine-mediated cross-linking [25]. After cells are pre-treated with 2-BP for 16-24 hours to expose normally palmitoylated cysteines, the cysteines can be cross-linked using any of the following methods: a) Spontaneous oxidation in Brij97 lysates (a condition that preserves tetraspanin-tetraspanin associations), b) In situ cross-linking, by pre-lysis oxidation of cells with Cu2+-phenanthroline (CuP) to promote disulfide bond formation. c) In situ cross-linking with thiol-reactive cross-linking agents of defined length (e.g. DTME, BMB). The first two approaches produce in essence "zero-length" disulfides, indicative of close proximity of target cysteines and presumably high specificity of interaction. In contrast, chemical cross-linkers with 6-20 A spacer arm may cross-link with higher efficiency, but not necessarily higher specificity. However, they provide advantages such as variable membrane permeability, and potential linkage cleavability. For tetraspanins such as CD9, membrane-permeable cross-linker DTME (13.3 A-long, reducible) provides highly specific and efficient cross-linking [25]. Here we have used a cysteine cross-linking strategy, in combination with cysteine-scanning mutagenesis, to map the residues from TM1 and TM2 contributing to the CD9 dimerization interface.
###end p 39
###begin p 40
###xml 284 286 284 286 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B36">36</xref>
###xml 439 440 439 440 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5</xref>
For subsequent cross-linking experiments using CD9 TM(1+2)-GFP protein, the non-dimerizing form of GFP was used. This avoids potential GFP-dependent dimerization and aggregation that can be observed with wild-type GFP, especially when fusions with transmembrane proteins are studied [36]. Importantly, the Leu221Lys mutation in GFP prevented aggregation of mutant forms of CD9 TM(1+2), which was observed with wild-type GFP fusion (Figure 5). The TM(1+2) fragment of CD9 contains three native cysteines - Cys9, Cys78 and Cys79. Single-cysteine mutants of TM(1+2) were constructed, in which a cysteine was placed at various faces of TM1 or TM2 while all of the wild-type cysteines were simultaneously replaced by serines. The mutant proteins were transiently expressed in RD cells (having little endogenous CD9), which were then treated for 16-18 hours with 2-BP. To achieve maximal specificity in cross-linking we used a "zero-length" agent, CuP.
###end p 40
###begin p 41
###xml 357 358 357 358 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 360 361 360 361 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4</xref>
###xml 501 503 501 503 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F7">7A</xref>
###xml 831 833 831 833 <italic xmlns:xlink="http://www.w3.org/1999/xlink">g </italic>
###xml 831 833 831 833 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic>g </italic></bold>
###xml 837 839 837 839 <italic xmlns:xlink="http://www.w3.org/1999/xlink">c </italic>
###xml 837 839 837 839 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic>c </italic></bold>
###xml 885 886 885 886 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3</xref>
First, single-cysteine replacements were constructed for residues Leu14, Phe15, Gly16, Phe17 and Asn18, covering just over one complete helical turn at the beginning of TM1. While residue Asn18 is highly conserved, positions 14, 15 and 17 are occupied by bulky hydrophobic residues in most tetraspanins, whereas position 16 shows less conservation (Figures 1, 4). All of the single-cysteine mutants showed diffused pattern of protein localization, without any signs of aggregation. As shown in Figure 7A, the highest level of intermolecular cross-linking was observed for Leu14Cys and Phe17Cys mutants, a lower level for Phe15Cys and Gly16Cys mutants, and very little cross-linking for Asn18Cys substitution. These results indicate that: a) the first two transmembrane domains of CD9 alone can mediate its dimerization, and b) the g and c residues of TM1 (e.g. Leu14 and Phe17, Figure 3) are likely to be part of the intermolecular interface.
###end p 41
###begin p 42
###xml 287 289 287 289 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F7">7B</xref>
###xml 885 887 885 887 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F7">7C</xref>
Similarly, single-cysteine substitutions were made for residues Gly77, Gly80 and Ala81 in TM2; in addition, proteins carrying a single wild-type cysteine, Cys9, Cys78 or Cys79, were tested. No protein aggregation was observed for any of these single-cysteine mutants. As shown in Figure 7B, the relatively low level of intermolecular cross-linking of wild-type CD9 TM(1+2)-GFP protein was enhanced dramatically in single-cysteine TM2 mutants Gly80Cys and Ala81Cys. The Gly77Cys mutant also had an elevated level of cross-linking. In contrast, any of the three native cysteines (9, 78 and 79) produced level of cross-linking not much greater than the wild-type TM(1+2) protein. Similar results were obtained with cysteine-reactive cross-linker BMB (data not shown). Likewise, comparable results were obtained with single-cysteine mutants of untagged, full-length CD9, using CuP (Figure 7C) as well as DTME cross-linker (data not shown).
###end p 42
###begin p 43
###xml 163 164 163 164 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6</xref>
###xml 249 254 249 254 <underline xmlns:xlink="http://www.w3.org/1999/xlink">inter</underline>
###xml 285 287 285 287 <italic xmlns:xlink="http://www.w3.org/1999/xlink">c </italic>
###xml 285 287 285 287 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic>c </italic></bold>
###xml 291 293 291 293 <italic xmlns:xlink="http://www.w3.org/1999/xlink">g </italic>
###xml 291 293 291 293 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic>g </italic></bold>
###xml 326 328 326 328 <italic xmlns:xlink="http://www.w3.org/1999/xlink">g </italic>
###xml 326 328 326 328 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic>g </italic></bold>
###xml 366 368 366 368 <italic xmlns:xlink="http://www.w3.org/1999/xlink">e </italic>
###xml 366 368 366 368 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic>e </italic></bold>
###xml 372 374 372 374 <italic xmlns:xlink="http://www.w3.org/1999/xlink">f </italic>
###xml 372 374 372 374 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic>f </italic></bold>
These cross-linking results for TM1 and TM2 are consistent with our model that places residues Leu14, Phe17 and Gly80 on the same side of the TM1-TM2 pair (Figure 6, panel C). The strong cross-linking with Leu14Cys, Phe17Cys and Gly80Cys places the intermolecular interface toward the c and g phases of the TM1 helix, and the g phase of the TM2 helix, away from its e and f faces containing wild-type cysteines 78 and 79.
###end p 43
###begin p 44
###xml 219 221 219 221 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F8">8A</xref>
###xml 541 542 539 540 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6</xref>
Critical residues at the TM1-TM2 interface also affect dimerization indirectly. To assess specific CD9 dimerization, we used a Gly80Cys substitution at the intermolecular interface for cross-linking. As shown in Figure 8A, single replacements of conserved heptad residues in positions 18, 25, 32, 67 and 74 (Asn18Ser, Gly25/32/67/74-->Leu) strongly decreased the cross-linking mediated by Cys80. The effect was most pronounced for mutations of residues, Gly32 and Gly67, located in the tightly packed extracellular end of TM helices (Figure 6). In contrast, mutations of residues closer to the cytoplasmic end of TM2 (Gly74 and especially Ala81) had only modest to very little effect on cross-linking.
###end p 44
###begin p 45
###xml 104 108 104 108 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F7">7B,C</xref>
###xml 210 211 210 211 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3</xref>
###xml 564 566 564 566 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F8">8B</xref>
###xml 915 917 915 917 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F8">8C</xref>
###xml 1271 1282 1271 1282 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Discussion </italic>
Relatively low efficiency of intermolecular cross-linking via native residues Cys9, 78, and 79 (Figures 7B,C) correlates well with the predicted location of Cys78 and 79 away from the dimeric interface (Figure 3), and suggests that the extramembrane N-terminal part of CD9 (residues 1-13) does not self-associate. We next examined whether mutations of conserved Asn and Gly residues in TM1 and TM2 decreased low-level background cross-linking via native cysteines. As expected, these mutations had virtually no effect on dimer formation of CD9 TM(1+2)-GFP (Figure 8B). The level of covalent dimer formed was not diminished for triple Asn18Ser + Gly25Leu + Gly32Leu and double Gly67Leu + Gly74Leu mutants, compared to wild-type TM(1+2) CD9 molecule. Similarly, the same triple and double mutations in the context of full-length CD9-GFP protein (with six cysteines) produced wild-type levels of cross-linking (Figure 8C). We interpret these findings as evidence for at least two types of associations between CD9 molecules: primary, involving residues 14, 17 and 80, and dependent on integrity of conserved heptad residues in TM1 and TM2, and less efficient secondary interactions, probably representing random collision events, and independent of the heptad residues (see Discussion for more details).
###end p 45
###begin title 46
TM3 and TM4 cysteine residues in CD9 dimerization
###end title 46
###begin p 47
###xml 369 370 369 370 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F9">9</xref>
After identifying the roles of conserved TM1 and TM2 residues in CD9 dimerization, we next probed whether residues proximal to TM domains 3 and 4 are also involved. To this end, disulfide cross-linking of full-length CD9 molecules containing 3 C-terminal cysteines (87, just before TM3; 218 and 219 in TM4) or 3 N-terminal cysteines (9, 78 and 79) was compared (Figure 9). We found that the C-terminal cysteines were only slightly better than N-terminal cysteines with respect to detection of CD9 dimers. However, markedly more trimers and tetramers were detected using C-terminal cysteines. Thus, residues 87, 218 and 219 at TM3 and TM4 in CD9 can together form contacts across the dimeric interface and also additional contacts with other neighboring CD9 molecules.
###end p 47
###begin title 48
Discussion
###end title 48
###begin p 49
###xml 397 402 397 402 <underline xmlns:xlink="http://www.w3.org/1999/xlink">intra</underline>
###xml 711 716 711 716 <underline xmlns:xlink="http://www.w3.org/1999/xlink">inter</underline>
Here we provide the first detailed analysis of tetraspanin protein transmembrane domains. First, we show 1) the presence of a heptad repeat motif in TM1 and TM2, containing highly conserved Asn and Gly residues, 2) a leucine and glutamate/glutamine-containing heptad motif in TM3, and 3) high variability and absence of heptad repeats in TM4 sequences. Second, we provide evidence for a specific, intramolecular interaction between TM1 and TM2 domains, in which bulky hydrophobic residues pack against GG7 motif, and present a molecular model for this interaction. Third, experimental mapping of the CD9 dimerization interface firmly establishes an additional role for conserved TM1 and TM2 residues in dimeric intermolecular interactions. Fourth, preliminary evidence is provided to suggest that TM3 and TM4 domains contribute to expansion of CD9 dimers into higher order multimers.
###end p 49
###begin title 50
Conserved residues in TM1 and TM2 of tetraspanins: role in intramolecular packing
###end title 50
###begin p 51
###xml 192 194 192 194 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B35">35</xref>
###xml 313 314 313 314 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 611 613 611 613 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B37">37</xref>
###xml 614 616 614 616 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B38">38</xref>
###xml 833 835 833 835 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B39">39</xref>
###xml 836 838 836 838 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B40">40</xref>
###xml 1046 1048 1042 1044 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B41">41</xref>
###xml 1049 1051 1045 1047 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B42">42</xref>
###xml 1160 1162 1156 1158 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B43">43</xref>
###xml 1254 1256 1250 1252 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B44">44</xref>
###xml 1381 1383 1377 1379 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B45">45</xref>
###xml 1415 1417 1411 1413 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B46">46</xref>
###xml 1448 1450 1440 1442 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B47">47</xref>
###xml 1489 1491 1481 1483 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B48">48</xref>
###xml 1575 1577 1567 1569 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B49">49</xref>
###xml 1348 1365 <span type="species:ncbi:10870">bacteriophage M13</span>
###xml 1386 1391 <span type="species:ncbi:4932">yeast</span>
We hypothesized that the first two transmembrane domains of tetraspanins might interact with each other because: a) consecutive TM domains frequently associate in known protein 3D structures [35], and b) they both contain a series of highly conserved amino acids - several Gly residues and an Asn residue (Figure 1). Conserved Gly residues are a frequent theme in the organization of interacting transmembrane domains. Analysis of 3D helix packing in polytopic membrane proteins reveals that Gly residues tend to localize in buried positions, especially at the helix-helix interfaces and helix crossing points [37,38]. Due to the absence of a side chain, Gly provides a flat surface for packing of a side chain from another residue, without loss of side-chain entropy upon interaction. The most common Gly-containing motif is GxxxG [39,40]. In glycophorin A (GpA), the major glycoprotein in erythrocyte cell membranes, Gly79 and Gly83 are part of the LIxxGVxxGVxxT sequence that promotes homodimerization of parallel transmembrane alpha-helixes [41,42]. In the GpA dimerization motif, Gly residues allow for tight packing in the right-handed helical crossing [43]. There are also examples of left-handed helical crossing in the context of a GxxxG motif [44]. Other membrane proteins that use the GxxxG motif for homo- or heterodimerization include bacteriophage M13 coat proteins [45], yeast alpha factor receptor [46], integrin alpha IIb subunit [47], and ErbB1 receptor tyrosine kinase [48]. Other small residues, such as Ala and Ser, can substitute for Gly in this motif [49].
###end p 51
###begin p 52
###xml 177 179 177 179 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B50">50</xref>
###xml 473 480 473 480 <italic xmlns:xlink="http://www.w3.org/1999/xlink">et al. </italic>
###xml 481 483 481 483 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B51">51</xref>
###xml 552 554 552 554 <italic xmlns:xlink="http://www.w3.org/1999/xlink">a </italic>
###xml 552 554 552 554 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic>a </italic></bold>
###xml 558 560 558 560 <italic xmlns:xlink="http://www.w3.org/1999/xlink">d </italic>
###xml 558 560 558 560 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic>d </italic></bold>
###xml 581 589 581 589 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 819 821 805 807 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B52">52</xref>
A protein motif in which Gly residues are separated by 6 other residues (GG7) is also common in transmembrane helices, especially in transporter/channel-like membrane proteins [50]. However, the structural features associated with this motif are not well known. In particular, it is unclear whether left-handed GG7 heptad repeat motif (as opposed to the "classic" right-handed GxxxG motif) can drive membrane helix association. In a recent work addressing this issue, Lear et al. [51] showed that a synthetic peptide containing Gly at heptad positions a and d could self-associate in vitro, likely in an antiparallel orientation. Heptad repeats containing conserved Gly residues occur in TM domains of alpha and beta chains of MHC class II proteins, and mutations of the Gly residues disrupt the alphabeta heterodimer [52]. These examples demonstrate that Gly-based heptad motifs may be used for both intra- and intermolecular associations.
###end p 52
###begin p 53
###xml 599 601 599 601 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B44">44</xref>
In this work, we identified a highly conserved GG7 motif in the first two tetraspanin TM domains. The GG7 sequence in tetraspanins is a part of a larger motif that also includes a conserved Asn residue in TM1 (NGG7) and an Ala/Ser/Thr residue in TM2 (GGA7). The seven-residue periodicity of these motifs strongly suggests their involvement in left-handed coiled coil packing reminiscent of the leucine zipper, rather than right-handed packing of the GpA-like GxxxG motif. For antiparallel helices, the left-handed crossing is in fact predominant over the right-handed in known TM domain structures [44].
###end p 53
###begin p 54
###xml 224 225 224 225 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6</xref>
###xml 357 359 357 359 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B38">38</xref>
###xml 360 362 360 362 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B53">53</xref>
###xml 363 365 363 365 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B54">54</xref>
###xml 544 546 544 546 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B54">54</xref>
###xml 547 549 547 549 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B55">55</xref>
###xml 645 650 645 646 <sub xmlns:xlink="http://www.w3.org/1999/xlink">&#945;</sub>
###xml 651 654 647 650 <sup xmlns:xlink="http://www.w3.org/1999/xlink">...</sup>
###xml 692 694 688 690 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B44">44</xref>
###xml 716 721 712 713 <sub xmlns:xlink="http://www.w3.org/1999/xlink">&#945;</sub>
In our model, heptad Gly residues in NGG7 and GGA7 sequences provide specific packing between antiparallel tetraspanin TM1 and TM2 helices by allowing tight van der Waals interactions with large hydrophobic residues (Figure 6). Highly efficient packing of bulky side chains against glycine residues is observed in known transmembrane protein 3D structures [38,53,54]. An example includes packing of helices M1 and M2 in potassium channel KcsA, where Val91 in M2 is paired with Gly43 in M1, and Leu36 in M1 contacts Ala98 and Gly99 in helix M2 [54,55]. In addition to facilitating helix-helix packing, Gly residues frequently provide additional CalphaH...O hydrogen bonds between two helices [44]. In our model, two Calpha-backbone carbonyl H-bonds are predicted - between residues Gly27-Gly67, and Trp22-Met70.
###end p 54
###begin p 55
###xml 310 312 310 312 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B56">56</xref>
###xml 313 315 313 315 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B58">58</xref>
###xml 323 330 323 330 <italic xmlns:xlink="http://www.w3.org/1999/xlink">et al. </italic>
###xml 331 333 331 333 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B59">59</xref>
###xml 480 489 480 489 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 500 507 500 507 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli</italic>
###xml 767 769 767 769 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B60">60</xref>
###xml 500 507 <span type="species:ncbi:562">E. coli</span>
Although polar and charged amino acid residues (such as Asn in the TM1 heptad motif) are infrequent in transmembrane domains, they are functionally important. Polar residues such as glutamine, glutamic acid, aspartic acid and asparagine can promote strong oligomerization of model membrane-associated helices [56-58]. Ruan et al. [59] used asparagine scanning mutagenesis to probe the interface of self-associating polyleucine helices by detecting their enhanced self-interaction in vitro and in the E. coli-based ToxR assay. Thus, a hydrogen bond in an apolar environment can result in strong, though not necessarily specific, association of transmembrane helices. In fact, mutations to polar residues in transmembrane proteins are commonly associated with disease [60]. Because of this potential for non-specific interactions, polar residues tend to localize at buried positions in TM domains.
###end p 55
###begin p 56
###xml 194 195 194 195 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6</xref>
###xml 612 614 612 614 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F7">7A</xref>
In our case, the conserved Asn18 residue in CD9 is predicted to be a part of the TM1-TM2 interface, though our model does not predict any electrostatic interaction between Asn18 and TM2 (Figure 6). Consistently, substitution such as Asn18Tyr (and Gly77Leu) in TM(1+2)-GFP protein was not destabilizing as analyzed by protein aggregation. Curiously, the full-length Asn18Ser CD9 migrated slightly slower on SDS-PAGE gel (data not shown), suggesting that Asn18 does play a role in maintaining conformation of the molecule. The Asn18Cys single-cysteine mutant shows very little intermolecular cross-linking (Figure 7A), supporting the proposed location of this residue at the intramolecular interface. It is tempting to speculate that the "pocket" between TM1 and TM2 lined by Asn18 and Gly77 might be important for accommodating palmitate moieties that target Cys78 and Cys79 residues, and/or important for access by the putative palmitoyl transferase to those residues. Understanding the exact role of these highly conserved Asn18 and Gly77 residues in tetraspanins awaits further investigation.
###end p 56
###begin p 57
###xml 420 422 420 422 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B61">61</xref>
In summary, we identified conserved glycine residues of TM1 and TM2 of tetraspanins as key elements required for intramolecular packing. Mutations of these key residues (Gly25, Gly32, Gly67 and Gly74 in CD9) resulted in protein destabilization and aggregation. There is ample evidence in the literature for mutations in transmembrane proteins that lead to protein destabilization, misassembly and pathologic conditions [61]. Thus, we have identified conserved heptad Gly residues in TM1 and TM2 of tetraspanins as plausible targets of destabilizing mutations with potential functional consequences.
###end p 57
###begin title 58
Intermolecular interactions in tetraspanins
###end title 58
###begin p 59
###xml 99 101 99 101 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
###xml 442 444 442 444 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B62">62</xref>
###xml 487 489 487 489 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B63">63</xref>
###xml 492 500 492 500 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli </italic>
###xml 518 520 518 520 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B64">64</xref>
###xml 538 540 538 540 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B65">65</xref>
###xml 554 556 554 556 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B66">66</xref>
###xml 492 499 <span type="species:ncbi:562">E. coli</span>
Tetraspanin CD9 forms mostly homodimers, but also a low level of heterodimers with CD81 and CD151 [25]. Thus, mapping the dimerization interface is an important next step in structure-function analysis of tetraspanins. Disulfide-mediated cross-linking, often in combination with cysteine-scanning mutagenesis, is a common strategy to probe oligomerization or intersubunit interactions of transmembrane proteins such as histidine kinase EnvZ [62], M(3) muscarinic acetylcholine receptor [63], E. coli lactose permease [64], synaptobrevin [65], integrins [66] and many others. In tetraspanins such as CD9, membrane-proximal cysteine residues are especially useful targets for disulfide trapping, as their linkage can be enhanced by pre-treating cells with 2-BP. While the ability of wild-type cysteines in CD9 to be cross-linked may indicate that they are close to the dimerization interface, more precise mapping was achieved here using cysteine-scanning mutagenesis.
###end p 59
###begin p 60
###xml 437 438 437 438 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6</xref>
Our data clearly identify regions, near the cytoplasmic face of TM1 and TM2, important for dimerization. Intermolecular zero-length cross-linking was highest when single cysteines were placed in positions 14, 17, 77, 80 and 81 in TM(1+2)-GFP molecule, or at positions 77, 80 or 81 in the full-length CD9 protein. Positions 14, 17 and 80 are distinct from the intramolecular interface and are on the same side of the TM1-TM2 pair (Figure 6). Thus, they are well-positioned to participate in an interaction with another molecule. At the same time, the model predicts that wild-type cysteines (Cys78, 79), which do not yield very efficient zero-length cross-linking, are on the other side of TM1-TM2 pair.
###end p 60
###begin p 61
###xml 264 269 264 269 <underline xmlns:xlink="http://www.w3.org/1999/xlink">inter</underline>
###xml 339 344 339 344 <underline xmlns:xlink="http://www.w3.org/1999/xlink">intra</underline>
While using the cysteine at position 80 as the dimeric interface probe, mutations of conserved residues in TM1 and TM2 (especially Gly32 and Gly67 to Leu) clearly reduced intermolecular cross-linking. We do not suggest that those residues are directly involved in intermolecular interaction. Rather, we propose that destabilization of the intramolecular TM1-TM2 interaction by Gly to Leu substitutions (discussed above) causes an overall conformational change that reduces dimer formation.
###end p 61
###begin p 62
An Ala81Leu mutation did not reduce cross-linking via Cys80, even though single-cysteine Ala81Cys molecules themselves produced a high level of cross-linking. These results, together with data on Gly32Leu and Gly67Leu mutations, are consistent with our model predicting that helices 1 and 2 interact more tightly near the extracellular end and less at the cytoplasmic end. This would give more flexibility to a cysteine at position 81 and also limit the effect of an Ala81Leu mutation. Location of this residue at the membrane/cytoplasmic border could also make it more accessible to CuP reagent as compared to residues buried in TM domain, thus elevating the efficiency of disulfide formation of the Ala81Cys mutant.
###end p 62
###begin title 63
Multiple interfaces in tetraspanin molecules
###end title 63
###begin p 64
###xml 226 227 226 227 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F9">9</xref>
###xml 277 279 277 279 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
###xml 424 426 424 426 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F10">10</xref>
###xml 832 834 830 832 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F8">8C</xref>
###xml 1222 1224 1220 1222 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F8">8B</xref>
###xml 1822 1824 1816 1818 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B67">67</xref>
###xml 1825 1827 1819 1821 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B68">68</xref>
In the full-length CD9 molecules, the 3 C-terminal cysteines (Cys87, 218 and 219) located at or in TM3 and TM4 promoted efficient dimer and even more efficient oligomer formation compared to the 3 N-terminal cysteines (Figure 9). Cys87 alone can be used to capture CD9 dimers [25]. These results suggest the existence of two dimeric interfaces in CD9 molecule - the TM 1-2/1-2 interface and the TM 3-4/3-4 interface (Figure 10). In a TM(1+2) molecule, the destabilization of 1-2 interaction, e.g. by Gly-->Leu mutations, would affect the 1-2/1-2 interface, as discussed above. However, these mutations would not interfere with the 3-4/3-4 interface in a full-length molecule, which includes Cys87, 218 and 219. Thus, cross-linking of full-length molecules, containing all 6 cysteine residues, would be unaffected, as seen in Figure 8C. Furthermore, wild-type Cys9, Cys78 and Cys79 are apparently not at the primary 1-2/1-2 interface. Their relative inefficiency in cross-linking CD9 TM(1+2) protein likely reflects weak secondary contacts between the molecules, or possibly random collision events. Such events should be independent of mutations in the conserved Gly residues in TM1 and TM2, as was demonstrated in Figure 8B. The potential existence of two interfaces in tetraspanin molecules, 1-2/1-2 and 3-4/3-4, should provide enhanced flexibility for forming additional intermolecular contacts. Current understanding of tetraspanin microdomains assumes a few strong, primary homotypic and heterotypic tetraspanin complexes (e.g. CD9-CD9, CD9-CD81, CD151-alpha3 integrin, CD81-EWI2) that help bring together various other proteins, forming secondary-type associations. Such properties of tetraspanins may bring signaling molecules such as protein kinase C or phosphatidylinositol 4-kinase to the vicinity of integrins [67,68].
###end p 64
###begin p 65
###xml 165 166 165 166 <italic xmlns:xlink="http://www.w3.org/1999/xlink">a</italic>
###xml 165 166 165 166 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic>a</italic></bold>
###xml 229 230 229 230 <italic xmlns:xlink="http://www.w3.org/1999/xlink">d</italic>
###xml 229 230 229 230 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic>d</italic></bold>
The organization of the TM3 domain points to a potential role in protein-protein interactions. A motif of Leu-Leu-Glu(Gln) spaced 7 residues apart (heptad positions a), with highly conserved residues in two consecutive positions d, poses as a likely interaction module. If responsible for heterologous protein-protein interactions, it would form another distinct interface of tetraspanin molecule. Our preliminary data indicate that replacing the Leu and Glu residues in TM3 of CD9 with Ala has no effect on cell surface expression of the protein and its dimerization (data not shown). It remains to be tested if interactions with other proteins will be affected. Similarly, the TM4 domain may provide additional contributions to lateral tetraspanin associations. Much higher sequence variability, and the lack of a distinct heptad pattern suggests that TM4 is a major contributor to diversity among tetraspanin complexes. Structure-function analysis of TM3 and TM4 domains in tetraspanins is the subject of ongoing investigation.
###end p 65
###begin title 66
Conclusion
###end title 66
###begin p 67
###xml 28 33 28 33 <underline xmlns:xlink="http://www.w3.org/1999/xlink">intra</underline>
###xml 226 231 226 231 <underline xmlns:xlink="http://www.w3.org/1999/xlink">inter</underline>
###xml 471 476 471 476 <underline xmlns:xlink="http://www.w3.org/1999/xlink">inter</underline>
We have defined the TM1-TM2 intramolecular interface in tetraspanin CD9, providing evidence for glycines (Gly25 and Gly32 in TM1, Gly67 and Gly74 in TM2) packing against apposing bulky aliphatic residues. Second, we mapped an intermolecular CD9 interface (involved in CD9 homodimer formation) to the vicinity of residues Leu14 and Phe17 in TM1 and Gly77, Gly80 and Ala81 in TM2. Finally, we provide preliminary evidence that TM3 and TM4 in CD9 may contribute to a second intermolecular interface. Key CD9 residues involved in intra- and intermolecular interactions are highly conserved throughout the tetraspanin family, thus suggesting that our findings will apply to most tetraspanins.
###end p 67
###begin title 68
Methods
###end title 68
###begin title 69
Materials
###end title 69
###begin p 70
###xml 230 233 230 233 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bis</italic>
###xml 265 268 265 268 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Bis</italic>
###xml 493 497 493 497 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pfu </italic>
Cell culture reagents were from Invitrogen (Carlsbad, CA). 2-bromopalmitate was from Fluka (Milwaukee, WI), N-ethylmaleimide (NEM) and 1,10-phenanthroline were from Sigma-Aldrich (St. Louis, MO), and chemical cross-linkers dithio-bis-maleimidoethane (DTME) and 1,4-Bis-maleimidobutane (BMB) were purchased from Pierce Endogen (Rockford, IL). Triton X-100, protease inhibitor cocktail and FuGENE 6 transfection reagent were obtained from Roche (Indianapolis, IN). Restriction endonucleases and Pfu DNA polymerase were obtained New England Biolabs (Beverly, MA) and Stratagene (Carlsbad, CA), respectively. All other chemicals were purchased from Sigma-Aldrich or Fisher Scientific (Pittsburg, PA).
###end p 70
###begin title 71
Sequence analysis
###end title 71
###begin p 72
###xml 179 180 179 180 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 185 186 185 186 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T2">2</xref>
###xml 336 338 336 338 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B28">28</xref>
###xml 407 412 <span type="species:ncbi:9606">human</span>
Tetraspanin sequences were obtained from SWISS-PROT and GenBank databases. Locus designations, accession numbers and the most commonly used protein names are summarized in Tables 1 and 2. TM segments were delineated by inspection of hydrophobicity profiles, using database annotations and previous analyses of TM sequences as a guide ([28], M. Hemler, unpublished), and aligned manually. Residue numbers in human CD9 sequence are used a reference point throughout the study.
###end p 72
###begin title 73
DNA cloning and mutagenesis
###end title 73
###begin p 74
###xml 315 323 315 323 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HindIII </italic>
###xml 327 332 327 332 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PstI </italic>
###xml 370 375 370 375 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PstI </italic>
###xml 719 721 717 719 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B34">34</xref>
Sequence encoding CD9 protein was cloned into vector pcDNA3 (Invitrogen, Carlsbad, CA) and pEGFP-N1 (Clontech, Palo Alto, CA), for expression of untagged and C-terminally GFP-tagged CD9, respectively. pEGFP-N1 encoding CD9 TM(1+2) -GFP fusion protein was constructed by subcloning DNA for residues 1-83 of CD9 into HindIII and PstI sites of the vector; to introduce the PstI site, codon GTG for Val82 was changed to CTG (coding for Ala). In the resulting fusion protein, there is a 13-amino acid linker (with no cysteines) between CD9 and GFP. To minimize the low inherent ability of GFP to homodimerize, which could potentially influence the results of CD9 cross-linking, we used a monomeric GFP mutant, Leu221-->Lys [34], for cross-linking experiments.
###end p 74
###begin p 75
###xml 118 122 118 122 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pfu </italic>
Mutations were introduced in full-length and TM(1+2) CD9 proteins by a PCR-based strategy using mutagenic primers and Pfu DNA polymerase. All mutations were confirmed by DNA sequencing.
###end p 75
###begin title 76
Protein expression, microscopy, cysteine disulfide cross-linking and Western blotting
###end title 76
###begin p 77
###xml 86 91 <span type="species:ncbi:9606">human</span>
DNA constructs encoding TM(1+2)-GFP or full-length CD9 proteins were transfected into human rhabdomyosarcoma RD cells using the FuGENE 6 reagent. Cells expressing GFP fusion proteins were analysed by fluorescence microscopy 18-28 hours post-transfection. Images were captured using Spot 1.4.0 camera (Diagnostic Instruments, Sterling Heights, MI) attached to Nikon Eclipse TE300 microscope.
###end p 77
###begin p 78
###xml 280 281 279 280 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 315 317 314 316 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4 </sub>
For experiments involving cysteine-mediated cross-linking, cells were treated with 50 muM 2-BP starting 24-26 hours post-transfection and continuing for 16-18 hours. Cross-linking was carried out by incubating cells in HBSM buffer (25 mM Hepes-NaOH, pH 7.2, 150 mM NaCl, 2 mM MgCl2) containing either a) 0.6 mM CuSO4 and 1.8 mM 1,10-phenanthroline (CuP complex) or b) 0.2 mg/ml homobifunctional cysteine-reactive cross-linker (e.g. DTME), diluted from fresh 10 mg/ml solution in DMSO. After incubation for 10-15 minutes (with CuP) or 30-45 minutes (with cross-linker), cells were washed twice for 10 minutes with HBSM containing 10 mM NEM to block residual free cysteines. Cells were lysed in HBSM containing 1% Triton X-100, 0.1% SDS and a cocktail of protease inhibitors with 1 mM EDTA at 4degreesC for 45-60 minutes. Cell lysate was clarified by centrifugation at 14,000 x g for 15 minutes, an aliquot was removed, and proteins from it were precipitated by addition of trichloroacetic acid to 10% on ice followed by centrifugation at 14,000 x g for 10 minutes. After two washes with ice-cold acetone, protein pellet was solubilized in SDS-PAGE sample buffer without a reducing agent (50 mM Tris-HCl, pH 6.8, 1% SDS, 8% glycerol).
###end p 78
###begin p 79
In some experiments, CD9 protein was immunoprecipitated using monoclonal antibody Alb6 (Immunotech, Marseille, France). Proteins were separated by SDS-PAGE and analyzed by Western blotting using monoclonal antibody JL-8 (Clontech) for GFP or Alb6 for CD9. Bands from X-ray films were quantitated using GeneToolstrade mark software from Syngene (Frederick, MD).
###end p 79
###begin title 80
Modeling of TM1-TM2 interaction
###end title 80
###begin p 81
###xml 114 116 114 116 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B69">69</xref>
###xml 506 515 502 511 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vacuo </italic>
###xml 586 588 582 584 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B70">70</xref>
###xml 662 664 658 660 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B71">71</xref>
An atomic model of the CD9 TM1-TM2 dimer was constructed with a Monte Carlo-simulated annealing (MCSA) algorithm [69]. Two idealized alpha-helices corresponding to TM1 residues Tyr12 through Leu35 and TM2 residues Gly59 through Val82 were docked with six orthogonal parameters: three rigid body translations and three rotations. During each step of a MCSA cycle, there was an equal probability of changing either one parameter or all six parameters to random values. A conformation's energy was calculated in vacuo with the AMBER united-atom force field for van der Waals interactions [70]. The van der Waals term was modified as described by Kuhlman and Baker [71]. If a structure had favorable dimerization energy, the energies of select mutants were calculated. Structures were selected with a novel scoring function that maximizes the Boltzmann probability of dimerization for silent mutations while minimizing the probability for disruptive mutations. Asn18Ser, Gly77Leu, and Gly80Leu were scored as silent mutations while Gly25Leu, Gly32Leu, Gly67Leu, and Gly74Leu were considered to be disruptive. Each MCSA cycle consisted of 50,000 steps with an exponential temperature decay from 10,000 to 10 K.
###end p 81
###begin p 82
###xml 387 389 383 385 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B72">72</xref>
Ten MCSA cycles through global sample space were used to restrict the search area. Parameters were restricted to +/- 2 standard deviations from their mean value for structures within 10 kcal of the best structure. MCSA cycles were repeated as described above with additional optimization of chi values: rotamers at the protein-protein interface were optimized with Dead End Elimination [72], and chi values were further optimized with Monte Carlo. All MCSA cycles converged upon structures that were within a root mean squared deviation (RMSD) of 1.5 A with the best structure, and structures that scored within 5 kcal of the best score had an RMSD of less than 0.5 A with the best structure.
###end p 82
###begin title 83
List of abbreviations
###end title 83
###begin p 84
###xml 31 33 31 33 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
2-BP, 2-bromopalmitate; CuP, Cu2+-phenanthroline; DTME, dithio-bis-maleimidoethane; LEL, large extracellular loop; NEM, N-ethylmaleimide; TM, transmembrane (domain).
###end p 84
###begin title 85
Authors' contributions
###end title 85
###begin p 86
OVK carried out sequence comparisons, mutational analysis and cross-linking experiments, and drafted the manuscript. DGM built the TM1-TM2 interaction model and contributed to the manuscript. WFD supervised DGM's work. MEH coordinated the whole study and prepared the final manuscript.
###end p 86
###begin title 87
Acknowledgements
###end title 87
###begin p 88
We thank the rest of the Hemler laboratory for helpful discussions. This work was supported by the NIH grant GM38903 to MEH.
###end p 88
###begin article-title 89
Functional domains in tetraspanin proteins
###end article-title 89
###begin article-title 90
Tetraspanin proteins mediate cellular penetration, invasion and fusion events, and define a novel type of membrane microdomain
###end article-title 90
###begin article-title 91
Complexes of tetraspanins with integrins: more than meets the eye
###end article-title 91
###begin article-title 92
Tetraspanins: molecular organisers of the leukocyte surface
###end article-title 92
###begin article-title 93
###xml 51 55 <span type="species:ncbi:10090">mice</span>
Severely reduced female fertility in CD9-deficient mice
###end article-title 93
###begin article-title 94
###xml 64 68 <span type="species:ncbi:10090">mice</span>
The gamete fusion process is defective in eggs of CD9-deficient mice
###end article-title 94
###begin article-title 95
Requirement of CD9 on the egg plasma membrane for fertilization
###end article-title 95
###begin article-title 96
###xml 79 83 <span type="species:ncbi:10090">mice</span>
Normal lymphocyte development but delayed humoral immune response in CD81-null mice
###end article-title 96
###begin article-title 97
###xml 88 92 <span type="species:ncbi:10090">mice</span>
Normal development but differentially altered proliferative responses of lymphocytes in mice lacking CD81
###end article-title 97
###begin article-title 98
###xml 20 24 <span type="species:ncbi:10090">mice</span>
Characterization of mice lacking the tetraspanin superfamily member CD151
###end article-title 98
###begin article-title 99
An extracellular site on tetraspanin CD151 determines alpha 3 and alpha 6 integrin-dependent cellular morphology
###end article-title 99
###begin article-title 100
Residues SFQ (173-175) in the large extracellular loop of CD9 are required for gamete fusion
###end article-title 100
###begin article-title 101
CD81 extracellular domain 3D structure: insight into the tetraspanin superfamily structural motifs
###end article-title 101
###begin article-title 102
Structure of the tetraspanin main extracellular domain. A partially conserved fold with a structurally variable domain insertion
###end article-title 102
###begin article-title 103
The tetraspanin superfamily: molecular facilitators
###end article-title 103
###begin article-title 104
CD9, CD63, CD81, and CD82 are components of a surface tetraspan network connected to HLA-DR and VLA antigens
###end article-title 104
###begin article-title 105
Evaluation of prototype TM4SF protein complexes and their relation to lipid rafts
###end article-title 105
###begin article-title 106
Multiple levels of interactions within the tetraspanin web
###end article-title 106
###begin article-title 107
Expression of the palmitoylation-deficient CD151 weakens the association of alpha 3beta 1 integrin with the tetraspanin-enriched microdomains and affects integrin-dependent signalling
###end article-title 107
###begin article-title 108
Differential stability of tetraspanin/tetraspanin interactions: role of palmitoylation
###end article-title 108
###begin article-title 109
Palmitoylation of tetraspanin proteins: modulation of CD151 lateral interactions, subcellular distribution, and integrin-dependent cell morphology
###end article-title 109
###begin article-title 110
Analysis of the CD151-alpha3beta1 integrin and CD151-tetraspanin interactions by mutagenesis
###end article-title 110
###begin article-title 111
Quality control of transmembrane domain assembly in the tetraspanin CD82
###end article-title 111
###begin article-title 112
Association of a tetraspanin CD9 with CD5 on the T cell surface: role of particular transmembrane domains in the association
###end article-title 112
###begin article-title 113
Evidence for specific tetraspanin homodimers: inhibition of palmitoylation makes cysteine residues available for cross-linking
###end article-title 113
###begin article-title 114
Tetraspanins and malignancy
###end article-title 114
###begin article-title 115
Specific tetraspanin functions
###end article-title 115
###begin article-title 116
KAI1, a prostate metastasis suppressor: prediction of solvated structure and interactions with binding partners; integrins, cadherins, and cell-surface receptor proteins
###end article-title 116
###begin article-title 117
Coiled coils: a highly versatile protein folding motif
###end article-title 117
###begin article-title 118
Interaction of transmembrane helices by a knobs-into-holes packing characteristic of soluble coiled coils
###end article-title 118
###begin article-title 119
Coiled coils: new structures and new functions
###end article-title 119
###begin article-title 120
Extended knobs-into-holes packing in classical and complex coiled-coil assemblies
###end article-title 120
###begin article-title 121
X-ray structure of the GCN4 leucine zipper, a two-stranded, parallel coiled coil
###end article-title 121
###begin article-title 122
Partitioning of lipid-modified monomeric GFPs into membrane microdomains of live cells
###end article-title 122
###begin article-title 123
Helix packing in membrane proteins
###end article-title 123
###begin article-title 124
Formation of stacked ER cisternae by low affinity protein interactions
###end article-title 124
###begin article-title 125
Internal packing of helical membrane proteins
###end article-title 125
###begin article-title 126
Helix packing in polytopic membrane proteins: role of glycine in transmembrane helix association
###end article-title 126
###begin article-title 127
The GxxxG motif: a framework for transmembrane helix-helix association
###end article-title 127
###begin article-title 128
Statistical analysis of amino acid patterns in transmembrane helices: the GxxxG motif occurs frequently and in association with beta-branched residues at neighboring positions
###end article-title 128
###begin article-title 129
Glycophorin A dimerization is driven by specific interactions between transmembrane alpha-helices
###end article-title 129
###begin article-title 130
A dimerization motif for transmembrane alpha-helices
###end article-title 130
###begin article-title 131
A transmembrane helix dimer: structure and implications
###end article-title 131
###begin article-title 132
###xml 14 17 14 17 <sup xmlns:xlink="http://www.w3.org/1999/xlink">...</sup>
The Calpha - H...O hydrogen bond: a determinant of stability and specificity in transmembrane helix interactions
###end article-title 132
###begin article-title 133
###xml 90 99 <span type="species:ncbi:10870">phage M13</span>
Val-->Ala mutations selectively alter helix-helix packing in the transmembrane segment of phage M13 coat protein
###end article-title 133
###begin article-title 134
###xml 129 134 <span type="species:ncbi:4932">yeast</span>
Oligomerization, biogenesis, and signaling is promoted by a glycophorin A-like dimerization motif in transmembrane domain 1 of a yeast G protein-coupled receptor
###end article-title 134
###begin article-title 135
Dimerization of the transmembrane domain of integrin alphaIIb subunit in cell membranes
###end article-title 135
###begin article-title 136
Two motifs within a transmembrane domain, one for homodimerization and the other for heterodimerization
###end article-title 136
###begin article-title 137
GXXXG and AXXXA: common alpha-helical interaction motifs in proteins, particularly in extremophiles
###end article-title 137
###begin article-title 138
Genomic analysis of membrane protein families: abundance and conserved motifs
###end article-title 138
###begin article-title 139
Association of a model transmembrane peptide containing Gly in a heptad sequence motif
###end article-title 139
###begin article-title 140
Role of transmembrane domain interactions in the assembly of class II MHC molecules
###end article-title 140
###begin article-title 141
Helix-helix packing and interfacial pairwise interactions of residues in membrane proteins
###end article-title 141
###begin article-title 142
###xml 2 4 2 4 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
Ca2+-ATPase structure in the E1 and E2 conformations: mechanism, helix-helix and helix-lipid interactions
###end article-title 142
###begin article-title 143
The structure of the potassium channel: molecular basis of K+ conduction and selectivity
###end article-title 143
###begin article-title 144
Interhelical hydrogen bonding drives strong interactions in membrane proteins
###end article-title 144
###begin article-title 145
Asparagine-mediated self-association of a model transmembrane helix
###end article-title 145
###begin article-title 146
Polar side chains drive the association of model transmembrane peptides
###end article-title 146
###begin article-title 147
The interface of a membrane-spanning leucine zipper mapped by asparagine-scanning mutagenesis
###end article-title 147
###begin article-title 148
Polar mutations in membrane proteins as a biophysical basis for disease
###end article-title 148
###begin article-title 149
Disease-related misassembly of membrane proteins
###end article-title 149
###begin article-title 150
Probing catalytically essential domain orientation in histidine kinase EnvZ by targeted disulfide crosslinking
###end article-title 150
###begin article-title 151
Use of an in situ disulfide cross-linking strategy to map proximities between amino acid residues in transmembrane domains I and VII of the M3 muscarinic acetylcholine receptor
###end article-title 151
###begin article-title 152
###xml 82 99 82 99 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Escherichia coli </italic>
###xml 82 98 <span type="species:ncbi:562">Escherichia coli</span>
Surface-exposed positions in the transmembrane helices of the lactose permease of Escherichia coli determined by intermolecular thiol cross-linking
###end article-title 152
###begin article-title 153
Synaptobrevin transmembrane domain dimerization-revisited
###end article-title 153
###begin article-title 154
A specific interface between integrin transmembrane helices and affinity for ligand
###end article-title 154
###begin article-title 155
Specific interactions among transmembrane 4 superfamily (TM4SF) proteins and phosphatidylinositol 4-kinase
###end article-title 155
###begin article-title 156
TM4SF proteins associate with activated PKC and link PKC to specific beta1 integrins
###end article-title 156
###begin article-title 157
A push-pull mechanism for regulating integrin function
###end article-title 157
###begin article-title 158
A new force field for molecular mechanical simulation of nucleic acids and proteins
###end article-title 158
###begin article-title 159
Native protein sequences are close to optimal for their structures
###end article-title 159
###begin article-title 160
The dead-end elimination theorem and its use in protein side-chain positioning
###end article-title 160
###begin title 161
Figures and Tables
###end title 161
###begin p 162
###xml 0 80 0 80 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Sequence alignment of the transmembrane domains 1 and 2 of 28 human tetraspanins</bold>
###xml 62 67 <span type="species:ncbi:9606">human</span>
Sequence alignment of the transmembrane domains 1 and 2 of 28 human tetraspanins. Residues from select positions of the heptad motifs in TM1 and 2 are highlighted (see text for details). Also highlighted are polar residues and cysteines. Consensus residue types are shown by the color scheme indicated. Boxed residues reflect correlated substitutions for position pairs 22-74 and 25-70 (details are in the text). The numbers refer to CD9 sequence.
###end p 162
###begin p 163
###xml 0 80 0 80 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Sequence alignment of the transmembrane domains 3 and 4 of 28 human tetraspanins</bold>
###xml 113 115 113 115 <italic xmlns:xlink="http://www.w3.org/1999/xlink">a </italic>
###xml 113 115 113 115 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic>a </italic></bold>
###xml 119 121 119 121 <italic xmlns:xlink="http://www.w3.org/1999/xlink">d </italic>
###xml 119 121 119 121 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic>d </italic></bold>
###xml 62 67 <span type="species:ncbi:9606">human</span>
Sequence alignment of the transmembrane domains 3 and 4 of 28 human tetraspanins. Residues from heptad positions a and d in TM3 are highlighted. Also highlighted are the conserved Glu/Gln residue in TM4, other polar residues and cysteines. The color scheme is as in Figure 1.
###end p 163
###begin p 164
###xml 0 92 0 92 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Helical wheel diagrams of transmembrane domains TM1-4 reflecting the consensus residue types</bold>
###xml 182 184 182 184 <italic xmlns:xlink="http://www.w3.org/1999/xlink">a </italic>
###xml 182 184 182 184 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic>a </italic></bold>
###xml 192 194 192 194 <italic xmlns:xlink="http://www.w3.org/1999/xlink">g </italic>
###xml 192 194 192 194 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic>g </italic></bold>
###xml 261 263 261 263 <italic xmlns:xlink="http://www.w3.org/1999/xlink">a </italic>
###xml 261 263 261 263 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic>a </italic></bold>
###xml 267 269 267 269 <italic xmlns:xlink="http://www.w3.org/1999/xlink">e </italic>
###xml 267 269 267 269 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic>e </italic></bold>
###xml 280 282 280 282 <italic xmlns:xlink="http://www.w3.org/1999/xlink">a </italic>
###xml 280 282 280 282 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic>a </italic></bold>
###xml 286 288 286 288 <italic xmlns:xlink="http://www.w3.org/1999/xlink">d </italic>
###xml 286 288 286 288 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic>d </italic></bold>
Helical wheel diagrams of transmembrane domains TM1-4 reflecting the consensus residue types. The color scheme is as in Figure 1. The numbers refer to CD9 sequence. Heptad positions a through g are indicated for TM1-3. A predicted interaction between positions a and e in TM1 and a and d in TM2 is shown by dotted lines (see Figure 6 and text for details). Arrows reflect the efficiency of intermolecular cross-linking via single cysteines placed in these positions (see Figure 7 and text for details).
###end p 164
###begin p 165
###xml 0 63 0 63 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Sequence alignment of TM1-3 for ten vertebrate orthologs of CD9</bold>
###xml 82 84 82 84 <italic xmlns:xlink="http://www.w3.org/1999/xlink">a </italic>
###xml 82 84 82 84 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic>a </italic></bold>
###xml 88 90 88 90 <italic xmlns:xlink="http://www.w3.org/1999/xlink">d </italic>
###xml 88 90 88 90 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic>d </italic></bold>
Sequence alignment of TM1-3 for ten vertebrate orthologs of CD9. Heptad positions a and d in TM1, TM2 and TM3 are highlighted in green. Residues that differ between orthologs are shown in yellow.
###end p 165
###begin p 166
###xml 0 74 0 74 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Expression of wild-type and mutant CD9 TM(1+2)-GFP proteins in human cells</bold>
###xml 63 68 <span type="species:ncbi:9606">human</span>
###xml 76 81 <span type="species:ncbi:9606">Human</span>
Expression of wild-type and mutant CD9 TM(1+2)-GFP proteins in human cells. Human rhabdomyosarcoma RD cells were transfected with constructs encoding CD9 TM(1+2)-GFP fusion proteins that carried mutations indicated. Either wild-type or monomeric (L221K) GFP was used. Images were captures 18-28 hours post-transfection.
###end p 166
###begin p 167
###xml 0 46 0 46 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Structural model of TM1-TM2 interaction in CD9</bold>
###xml 201 203 201 203 <italic xmlns:xlink="http://www.w3.org/1999/xlink">a </italic>
###xml 201 203 201 203 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic>a </italic></bold>
###xml 207 208 207 208 <italic xmlns:xlink="http://www.w3.org/1999/xlink">d</italic>
###xml 207 208 207 208 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic>d</italic></bold>
Structural model of TM1-TM2 interaction in CD9. Shown are space-filling models of CD9 TM1 (panel A), TM2 (panel B), and the two helices together (panel C). Small and large residues of heptad positions a and d, which form the crucial contacts between the helices, are shown in green and red, respectively. Asn18 is shown in blue, Leu14 and Phe17 in yellow, and Gly80 in light green.
###end p 167
###begin p 168
###xml 0 55 0 55 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Cross-linking of single-cysteine mutants of CD9 protein</bold>
###xml 100 102 100 102 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A </bold>
###xml 106 107 106 107 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B</bold>
###xml 144 145 144 145 <bold xmlns:xlink="http://www.w3.org/1999/xlink">C</bold>
###xml 413 415 413 415 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A </bold>
###xml 419 420 419 420 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B</bold>
###xml 436 437 436 437 <bold xmlns:xlink="http://www.w3.org/1999/xlink">C</bold>
###xml 307 312 <span type="species:ncbi:9606">human</span>
Cross-linking of single-cysteine mutants of CD9 protein. GFP fusions of CD9-TM(1+2) protein (panels A and B) or untagged full-length CD9 (panel C), and containing wild-type cysteines (Cys9,78,79), a single cysteine at positions indicated, or no cysteines (all replaced by Ser) were transiently expressed in human RD cells and cross-linked using CuP. Cell lysates were analyzed by Western blotting for GFP (panels A and B) or CD9 (panel C). % dimer is the fraction of dimer in total protein material (monomer + dimer), based on densitometry measurements of respective bands.
###end p 168
###begin p 169
###xml 0 74 0 74 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Effect of mutations in conserved TM1 and TM2 residues on CD9 cross-linking</bold>
###xml 164 165 164 165 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A</bold>
###xml 295 296 295 296 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B</bold>
###xml 402 403 402 403 <bold xmlns:xlink="http://www.w3.org/1999/xlink">C</bold>
Effect of mutations in conserved TM1 and TM2 residues on CD9 cross-linking. RD cells were transfected with constructs encoding the following fusion proteins: panel A, CD9 TM(1+2)-GFP, either wild-type or single-cysteine G80C mutant, which also carries TM1 and TM2 substitutions indicated; panel B, CD9 TM(1+2)-GFP with no cysteines or wild-type cysteines (Cys9,78,79) plus TM1 and TM2 mutations; panel C, full-length CD9-GFP with TM1 and TM2 mutations indicated. The proteins were cross-linked and analyzed by GFP Western as in Figure 7. % dimer was calculated as for Figure 7.
###end p 169
###begin p 170
###xml 0 60 0 60 <bold xmlns:xlink="http://www.w3.org/1999/xlink">CD9 cross-linking through N- or C-terminal cysteine residues</bold>
CD9 cross-linking through N- or C-terminal cysteine residues. RD cells were transfected with constructs encoding wild-type CD9 protein, CD9 containing only the three N-terminal cysteines (Cys9, 78 and 79), or the three C-terminal cysteines (Cys87, 218 and 219). Cells were treated with 2-BP for 16 hours and lysed in buffer containing 1% Brij97 for spontaneous disulfide cross-linking. Cell lysates were analyzed by CD9 Western. Relative intensity of bands corresponding to CD9 monomers, dimers, trimers and tetramers was calculated as a percent fraction of total protein material (monomers through tetramers).
###end p 170
###begin p 171
###xml 0 50 0 50 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A model of the organization of a tetraspanin dimer</bold>
A model of the organization of a tetraspanin dimer. Two interfaces, the intramolecular TM1/TM2 and intermolecular TM1-TM2/TM1-TM2, have been analysed in this work. A third interface, intermolecular TM3-TM4/TM3-TM4, is predicted.
###end p 171
###begin p 172
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human tetraspanin sequences analyzed in this study.
###end p 172
###begin p 173
Vertebrate CD9 orthologs analyzed in this study.
###end p 173

